Healthdyne takeover fight goes to court
This article was originally published in Clinica
Executive Summary
A US court could rule this week on a key element of Invacare's long-running hostile takeover bid for Healthdyne Technologies. At stake at the federal court hearing will be whether Healthdyne's anti-takeover defence mechanism should be overturned to allow shareholders to vote on new directors who support Invacare, says Invacare lawyer Mark Harnett. Invacare has asked for an expedited ruling prior to Healthdyne's annual meeting on July 30.
You may also be interested in...
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.